Building on our previous findings that demonstrated PTN overexpression in RRMS patients relative to HCS [14], the present study aims to investigate the PTN signaling axis in greater mechanistic detail by examining the expression of its principal receptors (PTPRZ, ALK, SDC3, and ITGB3) in PBMCs. The gene discussed is PTN; the disease is relapsing-remitting multiple sclerosis.